Harrow, Inc.
HROW
#5843
Rank
A$1.81 B
Marketcap
A$48.26
Share price
-0.09%
Change (1 day)
-20.91%
Change (1 year)

Earnings for Harrow, Inc. (HROW)

Earnings in 2026 (TTM): -A$13.89 Million

According to Harrow, Inc.'s latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$34.26 Million, an increase over its 2024 earnings that were of A$8.2 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Harrow, Inc. from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$13.89 Million-140.53%
2025 A$34.26 M317.34%
2024 A$8.2 M-329.09%
2023 -A$3.59 Million-224.34%
2022 A$2.88 M3.01%
2021 A$2.79 M149.06%
2020 A$1.12 M434.29%
2019 A$0.21 M-102.68%
2018 -A$7.84 Million-57.11%
2017 -A$18.27 Million-21.93%
2016 -A$23.4 Million5.11%
2015 -A$22.27 Million46.16%
2014 -A$15.24 Million32.68%
2013 -A$11.48 Million42.63%
2012 -A$8.05 Million
2010 -A$3.72 Million-45.76%
2009 -A$6.86 Million21.83%
2008 -A$5.63 Million-491.97%
2007 A$1.43 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-A$0.24 Billion 1,423.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-A$27.27 Million 73.81%๐Ÿ‡บ๐Ÿ‡ธ USA